JPRN-jRCT2080221846未知4 期
A Multicenter, Open-Label, Long-Term Study to Evaluate the Efficacy and Safety of LY2439821 in Japanese Patients with Moderate-to-Severe Psoriasis
适应症
试验速览
- 阶段
- 4 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •male or female patients aged 20 years or older who have the following:
- •Chronic Ps based on a confirmed diagnosis for at least 6 months prior to baseline (Week 0; Visit 2), a PASI score no less than 12, an sPGA score of no less than 3, and have no less than 10% BSA involvement at both Screening (Visit 1) and baseline (Week 0; Visit 2)
- •Are candidates for phototherapy and/or systemic therapy
排除标准
- 未提供
研究者
相似试验
未知
3 期
A Multicenter, Open-Label, Long-Term Study to Evaluate the Safety and Efficacy of OVF in Patients With Cancer and Breakthrough PaiCancer pain (breakthrough pain)JPRN-jRCT2080220447Taiho Pharmaceutical Co., Ltd.
已完成
4 期
A Clinical Trial to evaluate the safety and Tolerability of Treatment in Adolscent patients with Schizophrenia.CTRI/2012/09/002953Otsuka Pharmaceutical Development and Commercialization Inc250
进行中（未招募）
不适用
An open label study assessing safety and tolerability of aripirazole in Adolescent Patients with Schizophrenia or Child and Adolescent Patients with Bipolar I Disorder.Schizophrenia in Adolescent Patients or Child and Adolescent Patients with Bipolar I Disorder, Manic or Mixed Episode with or without Psychotic FeaturesMedDRA version: 14.1Level: PTClassification code 10039626Term: SchizophreniaSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 14.1Level: PTClassification code 10004939Term: Bipolar I disorderSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2010-018911-13-PLOtsuka Pharmaceutical Development & Commercialization, Inc.300
进行中（未招募）
不适用
An open label study assessing safety and tolerability of aripirazole in Adolescent Patients with Schizophrenia or Child and Adolescent Patients with Bipolar I Disorder.EUCTR2010-018911-13-HUOtsuka Pharmaceutical Development & Commercialization, Inc.350
进行中（未招募）
1 期
MT10109L in the Long-term, Open-label Treatment of Glabellar Lines and Lateral Canthal LinesGlabellar Lines & Lateral Canthal LinesMedDRA version: 21.1Level: LLTClassification code 10052609Term: Glabellar frown linesSystem Organ Class: 100000004858EUCTR2014-005303-24-DEMedytox Inc800